Ultromics is a UK-based clinical AI company, spun out of the University of Oxford and backed by GV, whose EchoGo platform applies FDA 510(k)-cleared AI to routine echocardiograms to help clinicians detect heart failure with preserved ejection fraction (HFpEF) and cardiac amyloidosis. -
View it on GitHub